530
Participants
Start Date
June 29, 2020
Primary Completion Date
December 31, 2025
Study Completion Date
September 1, 2026
Toripalimab combined with Lenvatinib
"Experimental group:~Toripalimab, 240mg, IV infusion, every 3 weeks (q3w). combined with Lenvatinib 12 mg/day (Body Weight≥60 kg) or 8 mg/day (Body Weight\<60 kg) oral administration, once daily. Continuous infusion, in a cycle of 3 weeks (21 days), until occurrence of termination event specified in the protocol."
Placebo combined with Lenvatinib
"Control group:~Placebo, one unit, IV infusion, once every 3 weeks, combined with Lenvatinib 12 mg/day (Body Weight≥60 kg) or 8 mg/day (Body Weight\<60 kg) oral administration, once daily. Continuous infusion, in a cycle of 3 weeks (21 days), until occurrence of termination event specified in the protocol."
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico,Oncologia Medica, Milan
Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command, Nanjing
"AOUI Verona - Policlinico G.B. Rossi di Borgo Roma", Verona
Communal Non-commercial Enterprise of Sumy Regional Council, Sumy Regional Clinical Oncological Dispensar, Sumy
Communal Enterprise Volyn Regional Clinical Hospital of Volyn Regional Council, Lutsk
Communal Non-commercial Enterprise City Clinical Hospital #4 of Dnipro City Council, Department of Chemotherapy, Dnipro
Azienda Ospedaliera Universitaria Careggi, Florence
Azienda Ospedaliero Universitaria Pisana, Pisa
"Communal Non-profit Enterprise Regional Center of Oncology, Department of Abdominal Organs Oncosurgery", Kharkiv
Communal Non-Profit Institution of Kharkiv Regional Council Regional Clinical Specialized Dispensary of Radiation Protection of Population, Kharkiv
Communal Non-commercial Enterprise Odesa Regional Clinical Hospital of Odesa Regional Council, Department of General Surgery, Odesa
Communal Non-commercial Enterprise Zaporizhzhia Regional Antitumor Center of Zaporizhzhia Regional Council, Zaporizhzhia
IRCCS Fondazione Giovanni Pascale, Istituto Nazionale Dei Tumori, Napoli
National Cancer Centre Singapore, Singapore
A.O.U. Citta della Salute e della Scienza di Torino, Tortona
Copernicus Podmiot Leczniczy sp. z o.o., Wojewodzkie Centrum Onkologii, Oddzial Onkologii Klinicznej/Chemioterapii, Gdansk
Szpital Wojewódzki im. Mikołaja Kopernika w Koszalinie, Oddzial Dzienny Chemioterapii, Koszalin
PRATIA MCM Kraków, ul. Pana Tadeusza 2,, Krakow
ID Clinic, Mysłowice
Wielkopolskie Centrum Onkologii, Oddział Onkologii Klinicznej i Immunoonkologii z Pododdziałem Dziennym i Izbą Przyjęć, Poznan
Centrum Medyczne Pratia Poznań, Skórzewo
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Klinika Onkologii i Radioterapii, Warsaw
State Inst. O.O.Shalimov Nat. scientific certer of Surgery and Transplantology of Nat. Academy of Med.Sciences of Ukraine, Dep.of Oncology, Kyiv
Shanghai Junshi Bioscience Co., Ltd.
OTHER